Flow Chemistry Meets AI and NMR for Next-Gen API Production

The PIPAc project is an innovative approach to pharmaceutical manufacturing that integrates AI, NMR, flow chemistry, and 3D-printed modular reactors. Attendees will explore how AI-driven process control optimizes chemical reactions in real time, while in-line NMR provides precise monitoring of active pharmaceutical ingredient (API) synthesis. Continuous flow chemistry combined with compact, 3D-printed reactors enable mobile, resource-efficient production, supporting rapid scale-up and flexible deployment. Gain in-depth insights into the convergence of automation, analytical technologies, and advanced reactor design shaping modern pharmaceutical production.

Presentations from the partners at the webinar

We are proud to share that Dr Guillaume Bentzinger, our Project Manager Process & Flow, will be a speaker at the event, together with:

– Alejandro Bara-Estaun, PhD, from Bruker Biospin
– Philippe Robin, Alysophil
– Luis Carrillo, De Dietrich France

What to expect

Discover how the PIPAc project integrates AI, NMR, flow chemistry, and 3D-printed reactors for compact, mobile API manufacturing. Learn about real-time process monitoring, continuous flow optimization, modular reactor design, and case studies showcasing efficient, scalable, and safe pharmaceutical production, providing actionable insights for modern API synthesis.

Discover more about the program and register to the webinar. We look forward to seeing you there.